● Sodium cromoglicate belongs to the group of anti-allergics used in ophthalmology (ATC code S01GX01) [2] ● Inhibits the degranulation of s
● Sodium cromoglicate belongs to the group of anti-allergics used in ophthalmology (ATC code S01GX01) [2]
● Inhibits the degranulation of sensitised mast cells after exposure to specific antigens and the release of histamine and membrane-derived mediators of inflammation [1][2]
● Has no intrinsic vasoconstrictor or antihistaminic activity [1][2]
● After topical ocular use, systemic absorption is low; the drug is not metabolised and is excreted unchanged in bile and urine [1][2]
● Sterile aqueous solution, clear colourless to pale yellow, sodium cromoglicate 2% w/v (20 mg/mL), in 0.4 mL single-dose units [1][2]
| Product Name | Sodium Cromoglicate Eye Drops 2% (20 mg/mL) 0.4 mL |
|---|---|
| Dosage Form | Ophthalmic |
| Strength | 2% (20 mg/mL) 0.4 mL |
| Standards | BP / ENTERPRISE |
| Packing | Customized per market requirement (bottle / blister / box) |
| Documents | COA, COPP, DMF, CTD Dossiers |
| MOQ | Contact us for MOQ and current stock |
Reference information summarised from WHO prescribing guidance. Expand each item below — clinical use must always follow the locally approved product insert.
Reference: WHO Model Formulary / WHO Model List of Essential Medicines. For professional reference only — clinical use must follow the locally approved product insert and national treatment guidelines.
Full batch testing and quality traceability under standard GMP workshops.
Sufficient stock on regular items, familiar with export logistics to 50+ countries.
COA, DMF, dossier and legalization documents for your market registration.
Every batch of Sodium Cromoglicate Eye Drops 2% (20 mg/mL) 0.4 mL ships with a Certificate of Analysis (COA). For market registration we provide COPP, DMF and CTD-format dossiers, plus legalisation support where your authority requires it.
MOQ and lead time for Sodium Cromoglicate Eye Drops 2% (20 mg/mL) 0.4 mL depend on strength, packaging and destination market. Send us your target market and annual volume — our export team confirms current stock, MOQ and lead time within 24 hours.
Yes. We offer OEM packaging and private-label production for Sodium Cromoglicate Eye Drops 2% (20 mg/mL) 0.4 mL, subject to the regulatory requirements of the destination market.
We have supplied ophthalmic products to 50+ countries across Africa, Southeast Asia, Latin America and the Middle East, with experience in ministry-of-health registration and international tenders.
Sodium Cromoglicate Eye Drops 2% (20 mg/mL) 0.4 mL is produced in China-GMP workshops (site re-inspected and passed in 2026), released only after full QC testing against BP / enterprise standards, with retained samples kept for one year beyond the product's expiry date.